AT&T shares rise after the company receives a pair of upgrades from analysts who laud the telecom giant’s plans to merge its WarnerMedia unit with Discovery.
Salesforce rises after the sales-tracking software giant receives an upgrade from Morgan Stanley on what it sees as a more optimistic long-term risk-reward outlook.
Microsoft Falls Despite Beating Quarterly Estimates
Microsoft topped analysts fiscal third quarter earnings and revenue expectations.
Author:
Original:
Shares of Microsoft (
MSFT) - Get Report were falling Tuesday after the tech giant reported its fiscal third-quarter results.
The Redmond, Washington software giant reported fiscal third-quarter earnings of $1.95 per share on revenue of $41.7 billion. Analysts were expecting earnings of $1.77 per share on revenue of $40.83 billion.
Follow TheStreet s live blog of Microsoft s earnings.
However, Microsoft shares were down 3.4% to $252.96 after hours on Tuesday. They are up 13.7% year to date, versus a gain of 11.5% for the S&P 500 over the same time period.
Bristol-Myers Gastric-Cancer Treatment Cleared by FDA
Bristol-Myers Squibb s Opdivo with chemotherapy was cleared by the FDA to treat patients with advanced gastric cancer.
Author:
Bristol-Myers Squibb (
BMY) - Get Report shares rose Friday after the Food and Drug Administration cleared the health-care giant to market Opdivo as a treatment for gastric cancer.
Opdivo as an injection combined with chemotherapy was cleared by the FDA to treat patients with advanced or metastatic gastric cancer, gastroesophageal junction cancer, and esophageal adenocarcinoma, the company said.
The approval is based on a Phase 3 trial.
“Historically, there has been little progress for patients diagnosed with these metastatic gastroesophageal adenocarcinomas,” said Adam Lenkowsky, general manager of oncology at the New York company.